SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SUNPHARM Pharmaceuticals (SUNP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Alys Hall who wrote (1)10/17/1997 7:29:00 AM
From: F. Jay Abella, III   of 52
 
Alys:

Nice to see you here. I am glad I don't have to talk to myself about this company. Have you read my report at www.westergaard.com/med/biotech.html? I suggest that you do. You will undoubtedly be impressed by (in no particular order);

1) The management
2) The ownership
3) The float (or lack therof)
4) The products and massive data they have generated
5) The capital structure
6) The present valuation versus my model
7) And, most refreshingly, the low key nature of its presentation.

Their upcoming near-term milestones are:

1) Announce results of small phase II study in AIDS related diarrhea
2) Submit data to FDA as end of Phase II meeting along with a Phase III protocol
3) If possible (and it just may be), initiate Phase III study by 1Q98 or earlier.

The market is anticipating good news on all fronts, witnessing the acceleration of the share price relative to the volume.

I would welcome your thoughts.

FJA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News